Webinar – High content in vitro imaging for translational success: targeted therapies

Nanolive hosts this event on “Non-invasive, high content live cell assays to increase translational relevance of in vitro drug development of biologics and small molecules”.

In this webinar, we present the following use-cases of our immuno-oncology and cytotoxicity assays from industry-leading biopharma companies to test toxicity, selectivity, uptake and expression of different targeted therapies.

  • Immune cell therapeutics:
    • Bispecific antibody screening in a T cell-target cell co-culture (Lightchain Bioscience)
  • Drug selectivity and cytotoxicity:
    • mRNA expression and cytotoxicity (TrON)
    • Drug selectivity in co-cultures: senolytics (dsm-firmenich)
    • Measuring particle uptake (bit.bio)

This webinar lasts 20 to 25 minutes.

3D Cell Explorer 96focus

Read our latest news

Nanolive at the SPS Annual Meeting September 18-20

Nanolive at the SPS Annual Meeting September 18-20

Joint presentation with Sanofi Nanolive is delighted to invite for you to attend our upcoming joint presentation with Sanofi at the Safety Pharmacology Society (SPS) Annual Meeting in Brussels on September 20, 2023, from 12:30 PM to 1:30 PM in Studio 214. During our...

Subscribe to our newsletter

  • This field is for validation purposes and should be left unchanged.